Filing Details

Accession Number:
0001209191-22-005117
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-26 19:35:06
Reporting Period:
2022-01-25
Accepted Time:
2022-01-26 19:35:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1706431 Vir Biotechnology Inc. VIR Biological Products, (No Disgnostic Substances) (2836) 812730369
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786378 Herbert Virgin C/O Vir Biotechnology, Inc.
499 Illinois Street, Suite 500
San Francisco CA 94158
Evp, Research & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-25 1,375 $1.53 109,075 No 4 M Direct
Common Stock Disposition 2022-01-25 1,375 $32.46 107,700 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-01-25 1,375 $0.00 1,375 $1.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
222,255 2028-01-26 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
  2. The option is fully vested and exercisable.